Hat Tip to the Wall Street Journal's Health Blog — and Lessons from the Trails It Blazed
The recently departed WSJ Health Blog taught us all lessons — and this blogger the lesson of standing up for what is clearly a better way of doing things.
The recently departed WSJ Health Blog taught us all lessons — and this blogger the lesson of standing up for what is clearly a better way of doing things.
In order to take best advantage of new digital technology, a publisher must identify new places and ways that products can be sold. New media requires new markets or the investment in digital media will simply be an unwelcome additional expense.
Amazon’s new local distribution technology allows academic institutions new levels of control.
What is the likely value of what PubMed Central is providing to eLife by publishing them free online, providing PubMed indexing without delay, and getting them into the market six months early?
Looking closely at nature reveals that our world is a world isolated by its scale, not by its reality. At other scales, other worlds exist.
Springer’s acquisition of Papers shifts the publisher into the workflow, and provides a unique opportunity to become a unifying resource.
More articles are published by PubMed Central at the behest of eLife. It seems taxpayer-funded publishing is just fine for this new group.
As communications in science begin to incorporate data elements more routinely, the standards for describing these, versioning these, and preserving these have to be considered. And we will all have to learn how to use data labeling processes correctly.
A recent incident involving Amazon and a Norwegian reader has highlighted the sad state of ebook distribution on many levels.
A fundamental confusion between articles and data leads to a call for more CC licenses and less copyright. But why are data being closed down while articles are being opened up? Is there a fundamental misunderstanding of copyright, licensing, and rights?
More information emerges about PubMed Central, its processes, its relationship with eLife, and its role as a technology provider. Overall, it looks like certain OA friends get special treatment, and the processes you think occur are often short-circuited and may not even be tracked.
Publishers have lost ground in the public debate of the role of publishing in scholarly communications. A new strategy is needed, one that emphasizes preemption, cooptation, and innovation.
Last week, PubMed Central became the primary and sole publisher of eLife content, putting its competition with publishers, its manipulation of PubMed indexing criteria, its competition with publishing technology companies, and its clear OA bias into stark relief.
The dark matter of social sharing may be visible now, thanks to some smart theory, not more data.
The era of Big Data raises many questions about why and how data should or can be preserved, who should lead the effort, and what the cost-benefit equation currently is.